CSL Behring LLC

King of Prussia, Pennsylvania, United States csl.com

Overview

CSL Behring is a global biotechnology company focused on the development of innovative biotherapies. As a subsidiary of CSL Limited, it specializes in treatments for rare and serious diseases, leveraging its expertise in immunology and hematology.

Therapeutic areas

ImmunologyHematologyRespiratoryCardiovascularNeurology

API / Drug Master Files

CSL Behring LLC holds 1 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • STERILE WATER FOR INJECTIONActive2006-03-17
  • ISCOMATRIX ADJUVANTInactive2009-10-29

FDA compliance signals

4 FDA enforcement records linked to this company.

  • 4832026-02-18

    Cleaning / Sanitizing / Maintenance

  • 4832026-02-18

    Procedures to be written and followed

  • 4832026-02-18

    Changes to Procedures Not Reviewed, Approved

  • 4832026-02-18

    Procedures not in writing, fully followed

Related companies

CSL Limited
Australia
AstraZeneca Pharmaceuticals LP
USA
Bristol-Myers Squibb Company
USA
Chartwell RX, LLC
United States
Global Biopharmaceuticals Inc.
USA
Globex Pharmaceuticals Inc.
USA
Grifols Biologicals LLC
United States
Health Innovations Incorporated
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo